{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:59Z","timestamp":1790712539189,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The skin barrier serves as the body\u2019s primary line of defense against exogenous insults and is critical for maintaining systemic homeostasis. Emerging evidence indicates that skin barrier dysfunction is not merely a secondary manifestation of psoriasis, but rather an early and pivotal pathogenic driver of the disease. It exerts bidirectional crosstalk with immune dysregulation, genetic predisposition and environmental triggers, collectively contributing to the initiation and progression of psoriasis. This review first elaborates on the normal structural composition and physiological functions of the skin barrier, followed by a discussion of the major etiological factors of psoriasis and the underlying mechanisms by which barrier impairment promotes psoriasis pathogenesis. These mechanisms include aberrant keratinocyte hyperproliferation, abnormal expression of structural proteins, tight junction disruption, aquaporin 3 dysfunction and dysregulated cutaneous lipid metabolism. Furthermore, we highlight the clinical significance of skin barrier restoration in psoriasis management and propose directions for future research. Elucidating the intricate crosstalk between skin barrier dysfunction and psoriasis pathogenesis will facilitate the identification of novel diagnostic biomarkers and the development of targeted therapeutic strategies for this disease.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1808904","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:37:17Z","timestamp":1782797837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Skin barrier dysfunction and correlation with the onset and progression of psoriasis"],"prefix":"10.3389","volume":"17","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Liang","sequence":"additional","affiliation":[{"name":"ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiao","family":"Xing","sequence":"additional","affiliation":[{"name":"ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Li","sequence":"additional","affiliation":[{"name":"ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Zhang","sequence":"additional","affiliation":[{"name":"ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111511","article-title":"Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches","volume":"9","author":"Campanati","year":"2021","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118508","article-title":"Transcriptional dysregulation of skin barrier genes in atopic dermatitis and psoriasis: Mechanistic insights and emerging therapeutic strategies","volume":"191","author":"Yang","year":"2025","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2019-0017","article-title":"Overcoming hurdles in iontophoretic drug delivery: Is skin the only barrier? - an update","volume":"10","author":"Gratieri","year":"2019","journal-title":"Ther Delivery"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1038\/ncomms8454","article-title":"Aquaporin-3-mediated hydrogen peroxide transport is required for NF-\u03baB signalling in keratinocytes and development of psoriasis","volume":"6","author":"Hara-Chikuma","year":"2015","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15185","article-title":"Lesional psoriasis is associated with alterations in the stratum corneum ceramide profile and concomitant decreases in barrier function","volume":"33","author":"Rousel","year":"2024","journal-title":"Exp Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100591","article-title":"Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: Results of a randomized controlled trial","volume":"65","author":"Rousel","year":"2024","journal-title":"J Lipid Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14263","article-title":"Efficacy and safety of a topical moisturizer containing linoleic acid and ceramide for mild-to-moderate psoriasis vulgaris: A multicenter randomized controlled trial","volume":"33","author":"Li","year":"2020","journal-title":"Dermatologic Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000534136","article-title":"The skin barrier and moisturization: Function, disruption, and mechanisms of repair","volume":"36","author":"Rajkumar","year":"2023","journal-title":"Skin Pharmacol Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bbalip.2013.12.004","article-title":"The important role of lipids in the epidermis and their ole in the formation and maintenance of the cutaneous barrier","volume":"1841","author":"Feingold","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.06.021","article-title":"Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis","volume":"185","author":"Gruber","year":"2015","journal-title":"Am J Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R700013-JLR200","article-title":"Thematic review series: Skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis","volume":"48","author":"Feingold","year":"2007","journal-title":"J Lipid Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102","article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101264","article-title":"The heterogeneity and complexity of skin surface lipids in human skin health and disease","volume":"93","author":"Mijaljica","year":"2024","journal-title":"Prog Lipid Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000491757","article-title":"Epidermal lamellar granules","volume":"31","author":"Wertz","year":"2018","journal-title":"Skin Pharmacol Physiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1597884","article-title":"Epidermal lamellar bodies, essential organelles for the skin barrier","volume":"13","author":"Leprince","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2018.03.005","article-title":"An overview of epidermal lamellar bodies: Novel roles in biological adaptations and secondary barriers","volume":"92","author":"Menon","year":"2018","journal-title":"J Dermatol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jsb.2006.12.006","article-title":"Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films","volume":"158","author":"Norl\u00e9n","year":"2007","journal-title":"J Struct Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2015.04.030","article-title":"Skin lipids: Localization of ceramide and fatty acid in the unit cell of the long periodicity phase","volume":"108","author":"Mojumdar","year":"2015","journal-title":"Biophys J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbalip.2013.11.006","article-title":"The important role of stratum corneum lipids for the cutaneous barrier function","volume":"1841","author":"van Smeden","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jaci.2014.05.048","article-title":"Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis","volume":"134","author":"Elias","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-014-2019-1","article-title":"Epidermal barrier disorders and corneodesmosome defects","volume":"360","author":"Haftek","year":"2015","journal-title":"Cell Tissue Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13111","article-title":"Retention of corneodesmosomes and increased expression of protease inhibitors in dandruff","volume":"171","author":"Singh","year":"2014","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2018.04.009","article-title":"Transepidermal water loss and skin conductance as barrier integrity tests","volume":"51","author":"Zhang","year":"2018","journal-title":"Toxicol Vitro"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13388","article-title":"Atopic skin: In vivo Raman identification of global molecular signature, a comparative study with healthy skin","volume":"27","author":"Verzeaux","year":"2018","journal-title":"Exp Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.jid.2018.09.001","article-title":"Research techniques made simple: Transepidermal water loss measurement as a research tool","volume":"138","author":"Alexander","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12768","article-title":"Skin pH mapping and its relationship with transepidermal water loss, hydration and disease severity in adult patients with atopic dermatitis","volume":"26","author":"Zainal","year":"2020","journal-title":"Skin Res Technol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S476004","article-title":"Skin barrier parameters in acne vulgaris versus normal controls: A cross-sectional analytic study","volume":"17","author":"Sukanjanapong","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031455","article-title":"The discovery and function of filaggrin","volume":"23","author":"Hoober","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0821-2","article-title":"Association between P478S\u00a0polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population\u00a0in Taiwan","volume":"300","author":"Chang","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12121171","article-title":"The role of sphingolipids in the pathogenesis of psoriasis","volume":"12","author":"Matwiejuk","year":"2022","journal-title":"Metabolites"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16083","article-title":"HLA-cw6 and psoriasis","volume":"178","author":"Chen","year":"2018","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_282_21","article-title":"HLA-Cw6 status and treatment responses between psoriasis patients","volume":"66","author":"Temel","year":"2021","journal-title":"Indian J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: A review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41598-023-28822-7","article-title":"Induction of psoriasis- and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix","volume":"13","author":"Morgner","year":"2023","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2017.07.040","article-title":"Imiquimod-induced psoriasis-like inflammation in differentiated human keratinocytes: Its evaluation using curcumin","volume":"813","author":"Varma","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08769.x","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.24","article-title":"TNF-\u03b1 downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-\u03b1 antagonists to improve skin barrier","volume":"131","author":"Kim","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: From keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0261-x","article-title":"Keratinocytes costimulate naive human T cells via CD2: A potential target to prevent the development of proinflammatory Th1 cells in the skin","volume":"17","author":"Orlik","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-012-9499-y","article-title":"Regulation of involucrin in psoriatic epidermal keratinocytes: The roles of ERK1\/2 and GSK-3\u03b2","volume":"66","author":"Chen","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03198-y","article-title":"The keratin-desmosome scaffold: Pivotal role of desmosomes for keratin network morphogenesis","volume":"77","author":"Moch","year":"2020","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20190017","article-title":"Keratin intermediate filaments: Intermediaries of epithelial cell migration","volume":"63","author":"Yoon","year":"2019","journal-title":"Essays Biochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051130","article-title":"Unbalanced sphingolipid metabolism and its\u00a0implications for the pathogenesis of psoriasis","volume":"25","author":"Boche\u0144ska","year":"2020","journal-title":"Molecules (Basel Switzerland)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01227-8","article-title":"Treatment of epidermolysis bullosa and future directions: A review","volume":"14","author":"Danescu","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: From simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2016.1174328","article-title":"Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis","volume":"27","author":"Muramatsu","year":"2017","journal-title":"Mod Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10400.x","article-title":"Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes","volume":"165","author":"Gutowska-Owsiak","year":"2011","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1153064","article-title":"Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis","volume":"25","author":"Malecic","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1714515","article-title":"Psoriasis: microbiome dysbiosis and pathogenic mechanisms","volume":"17","author":"Wang","year":"2026","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-7415-1_15","article-title":"Aquaporins in skin","volume":"1398","author":"Yin","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2012.24.2.168","article-title":"Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis","volume":"24","author":"Lee","year":"2012","journal-title":"Ann Dermatol"},{"key":"B57","article-title":"Expression of aquaporin-3 in psoriatic lesions and its significance","volume":"27","author":"Tang","year":"2018","journal-title":"Proceeding Clin Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.09.017","article-title":"Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide","volume":"1840","author":"Bienert","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1159\/000338190","article-title":"Effects of glyceryl glucoside on AQP3 expression, barrier function and hydration of human skin","volume":"25","author":"Schrader","year":"2012","journal-title":"Skin Pharmacol Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13888","article-title":"Improvements in epidermal function prevent relapse of psoriasis: a self-controlled study","volume":"44","author":"Man","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14431","article-title":"Decrease of ceramides\u00a0with long-chain fatty acids in psoriasis: Possible inhibitory effect of interferon gamma on chain elongation","volume":"31","author":"Kim","year":"2022","journal-title":"Exp Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12259","article-title":"Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial","volume":"28","author":"Liu","year":"2015","journal-title":"Dermatologic Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S443812","article-title":"Revolutionizing psoriasis topical treatment: Enhanced efficacy through ceramide\/phospholipid composite cerosomes co-delivery of cyclosporine and dithranol: in-vitro, ex-vivo, and in-vivo studies","volume":"19","author":"Elhabal","year":"2024","journal-title":"Int J Nanomed"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14080","article-title":"Keratinocyte aquaporin-3 expression induced by histone deacetylase inhibitors is mediated in part by peroxisome proliferator-activated receptors (PPARs)","volume":"29","author":"Yang","year":"2020","journal-title":"Exp Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1541776","article-title":"Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1335551","article-title":"Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition","volume":"11","author":"Dong","year":"2024","journal-title":"Front Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8693796","article-title":"Skin barrier dysfunction in chronic dermatoses: From pathophysiology to emerging therapeutic strategies","volume":"17","author":"Espinoza Urzua","year":"2025","journal-title":"Cureus"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:37:17Z","timestamp":1782797837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2026.1808904"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1808904","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1808904"}}